| Oncology |
| TUA Symposium A |
Recent Update on Life Extending Treatment that Target Androgen Axis in mCRPC |
| Lunch Symposium 1 |
The Evolving Armamentarium of mCRPC Treatment: How Does Enzalutamide Fit in the Present Paradigm? |
| Educational Course 3 |
Immune Checkpoint Inhibitors for GU Cancers |
| Prostate Cancer Forum |
Prostate Cancer Forum |
| TUA Symposium E |
Biomarkers and Overcoming Resistance in Prostate Cancer: from Bench to Bedside |
| TUA Symposium F |
VEGFR-TKI in Advanced RCC: Selection and Consideration |
| Meet the Experts 2 |
How to Optimize Survival Outcome for mCRPC Patients |
| Functional Urology |
| Urology Forum |
Botulinum Toxin A Injection in Lower Urinary Tract Diseases |
| PPCS/TUA Symposium |
PPCS/TUA Symposium |
| Educational Course 4 |
Urodynamic Interpretation of Voiding Dysfunction and Artifacts |
| EAU Lecture |
Current Treatment of Overactive Bladder |
| Lunch Symposium 4 |
Female Incontinence Solutions |
| Meet the Experts 3 |
Treatment Strategy of Overactive Bladder |
| Asian Urology Forum |
Male/Female Pediatric LUTS Treatment in Asia |
| TUA Symposium D |
Should We Use Different Methods to Treat Non-Neurogenic LUTS in Both Genders? |
| Andrology |
| TUA Symposium B |
Comprehensive Evaluation and Management for Patients with Ejaculatory Problem |
| Workshop 1 |
Tips of Common Surgery in Andrology |
| Lunch Symposium 3 |
The Science Evolution and Update of Tadalafil for ED and LUTS/BPH Treatment |
| Workshop 2 |
Microscopic Surgery in Urology |
| Endourology |
| TUA Symposium C |
Robotic vs Laparoscopic Radical Cystectomy for bladder cancer |
| Educational Course 2 |
Role of Fibrin Sealant and Haemostatic Agent in Endoscopic GU Surgery |
| Workshop 3 |
Flexible Ureterorenoscopy |
| Workshop 4 |
Advanced Robotic Partial Nephrectomy |
| Meet the Experts 1 |
Robotic Partial Nephrectomy : Indications /Expanding Indications /Complex Cases Presentation and Discussion |
| Asian Urology Forum |
Trends of Endoscopic/Laparoscopic/Robotic Surgery in Asia |